This research report focuses on the Vaccine Adjuvants Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
TABLE OF CONTENTS
1 Study Coverage
- 1.1 Vaccine Adjuvants Product Introduction
- 1.2 Market by Type
- 1.2.1 Global Vaccine Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Aluminum Adjuvant
- 1.2.3 Emulsions Adjuvant
- 1.2.4 Others
- 1.3 Market by Application
- 1.3.1 Global Vaccine Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Human Vaccine
- 1.3.3 Veterinary Vaccine
- 1.4 Study Objectives
- 1.5 Years Considered
2 Executive Summary
- 2.1 Global Vaccine Adjuvants Sales Estimates and Forecasts 2017-2028
- 2.2 Global Vaccine Adjuvants Revenue Estimates and Forecasts 2017-2028
- 2.3 Global Vaccine Adjuvants Revenue by Region: 2017 VS 2021 VS 2028
- 2.4 Global Vaccine Adjuvants Sales by Region
- 2.4.1 Global Vaccine Adjuvants Sales by Region (2017-2022)
- 2.4.2 Global Sales Vaccine Adjuvants by Region (2023-2028)
- 2.5 Global Vaccine Adjuvants Revenue by Region
- 2.5.1 Global Vaccine Adjuvants Revenue by Region (2017-2022)
- 2.5.2 Global Vaccine Adjuvants Revenue by Region (2023-2028)
- 2.6 North America
- 2.7 Europe
- 2.8 Asia-Pacific
- 2.9 Latin America
- 2.10 Middle East & Africa
3 Competition by Manufacturers
- 3.1 Global Vaccine Adjuvants Sales by Manufacturers
- 3.1.1 Global Top Vaccine Adjuvants Manufacturers by Sales (2017-2022)
- 3.1.2 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2017-2022)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccine Adjuvants in 2021
- 3.2 Global Vaccine Adjuvants Revenue by Manufacturers
- 3.2.1 Global Vaccine Adjuvants Revenue by Manufacturers (2017-2022)
- 3.2.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2017-2022)
- 3.2.3 Global Top 10 and Top 5 Companies by Vaccine Adjuvants Revenue in 2021
- 3.3 Global Vaccine Adjuvants Sales Price by Manufacturers (2017-2022)
- 3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Vaccine Adjuvants Manufacturers Geographical Distribution
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Global Vaccine Adjuvants Sales by Type
- 4.1.1 Global Vaccine Adjuvants Historical Sales by Type (2017-2022)
- 4.1.2 Global Vaccine Adjuvants Forecasted Sales by Type (2023-2028)
- 4.1.3 Global Vaccine Adjuvants Sales Market Share by Type (2017-2028)
- 4.2 Global Vaccine Adjuvants Revenue by Type
- 4.2.1 Global Vaccine Adjuvants Historical Revenue by Type (2017-2022)
- 4.2.2 Global Vaccine Adjuvants Forecasted Revenue by Type (2023-2028)
- 4.2.3 Global Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
- 4.3 Global Vaccine Adjuvants Price by Type
- 4.3.1 Global Vaccine Adjuvants Price by Type (2017-2022)
- 4.3.2 Global Vaccine Adjuvants Price Forecast by Type (2023-2028)
5 Market Size by Application
- 5.1 Global Vaccine Adjuvants Sales by Application
- 5.1.1 Global Vaccine Adjuvants Historical Sales by Application (2017-2022)
- 5.1.2 Global Vaccine Adjuvants Forecasted Sales by Application (2023-2028)
- 5.1.3 Global Vaccine Adjuvants Sales Market Share by Application (2017-2028)
- 5.2 Global Vaccine Adjuvants Revenue by Application
- 5.2.1 Global Vaccine Adjuvants Historical Revenue by Application (2017-2022)
- 5.2.2 Global Vaccine Adjuvants Forecasted Revenue by Application (2023-2028)
- 5.2.3 Global Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
- 5.3 Global Vaccine Adjuvants Price by Application
- 5.3.1 Global Vaccine Adjuvants Price by Application (2017-2022)
- 5.3.2 Global Vaccine Adjuvants Price Forecast by Application (2023-2028)
6 North America
- 6.1 North America Vaccine Adjuvants Market Size by Type
- 6.1.1 North America Vaccine Adjuvants Sales by Type (2017-2028)
- 6.1.2 North America Vaccine Adjuvants Revenue by Type (2017-2028)
- 6.2 North America Vaccine Adjuvants Market Size by Application
- 6.2.1 North America Vaccine Adjuvants Sales by Application (2017-2028)
- 6.2.2 North America Vaccine Adjuvants Revenue by Application (2017-2028)
- 6.3 North America Vaccine Adjuvants Market Size by Country
- 6.3.1 North America Vaccine Adjuvants Sales by Country (2017-2028)
- 6.3.2 North America Vaccine Adjuvants Revenue by Country (2017-2028)
- 6.3.3 U.S.
- 6.3.4 Canada
7 Europe
- 7.1 Europe Vaccine Adjuvants Market Size by Type
- 7.1.1 Europe Vaccine Adjuvants Sales by Type (2017-2028)
- 7.1.2 Europe Vaccine Adjuvants Revenue by Type (2017-2028)
- 7.2 Europe Vaccine Adjuvants Market Size by Application
- 7.2.1 Europe Vaccine Adjuvants Sales by Application (2017-2028)
- 7.2.2 Europe Vaccine Adjuvants Revenue by Application (2017-2028)
- 7.3 Europe Vaccine Adjuvants Market Size by Country
- 7.3.1 Europe Vaccine Adjuvants Sales by Country (2017-2028)
- 7.3.2 Europe Vaccine Adjuvants Revenue by Country (2017-2028)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia
8 Asia Pacific
- 8.1 Asia Pacific Vaccine Adjuvants Market Size by Type
- 8.1.1 Asia Pacific Vaccine Adjuvants Sales by Type (2017-2028)
- 8.1.2 Asia Pacific Vaccine Adjuvants Revenue by Type (2017-2028)
- 8.2 Asia Pacific Vaccine Adjuvants Market Size by Application
- 8.2.1 Asia Pacific Vaccine Adjuvants Sales by Application (2017-2028)
- 8.2.2 Asia Pacific Vaccine Adjuvants Revenue by Application (2017-2028)
- 8.3 Asia Pacific Vaccine Adjuvants Market Size by Region
- 8.3.1 Asia Pacific Vaccine Adjuvants Sales by Region (2017-2028)
- 8.3.2 Asia Pacific Vaccine Adjuvants Revenue by Region (2017-2028)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
- 8.3.12 Philippines
9 Latin America
- 9.1 Latin America Vaccine Adjuvants Market Size by Type
- 9.1.1 Latin America Vaccine Adjuvants Sales by Type (2017-2028)
- 9.1.2 Latin America Vaccine Adjuvants Revenue by Type (2017-2028)
- 9.2 Latin America Vaccine Adjuvants Market Size by Application
- 9.2.1 Latin America Vaccine Adjuvants Sales by Application (2017-2028)
- 9.2.2 Latin America Vaccine Adjuvants Revenue by Application (2017-2028)
- 9.3 Latin America Vaccine Adjuvants Market Size by Country
- 9.3.1 Latin America Vaccine Adjuvants Sales by Country (2017-2028)
- 9.3.2 Latin America Vaccine Adjuvants Revenue by Country (2017-2028)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina
10 Middle East and Africa
- 10.1 Middle East and Africa Vaccine Adjuvants Market Size by Type
- 10.1.1 Middle East and Africa Vaccine Adjuvants Sales by Type (2017-2028)
- 10.1.2 Middle East and Africa Vaccine Adjuvants Revenue by Type (2017-2028)
- 10.2 Middle East and Africa Vaccine Adjuvants Market Size by Application
- 10.2.1 Middle East and Africa Vaccine Adjuvants Sales by Application (2017-2028)
- 10.2.2 Middle East and Africa Vaccine Adjuvants Revenue by Application (2017-2028)
- 10.3 Middle East and Africa Vaccine Adjuvants Market Size by Country
- 10.3.1 Middle East and Africa Vaccine Adjuvants Sales by Country (2017-2028)
- 10.3.2 Middle East and Africa Vaccine Adjuvants Revenue by Country (2017-2028)
- 10.3.3 Turkey
- 10.3.4 Saudi Arabia
11 Company Profiles
- 11.1 GSK
- 11.1.1 GSK Corporation Information
- 11.1.2 GSK Overview
- 11.1.3 GSK Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.1.4 GSK Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 GSK Recent Developments
- 11.2 CSL Limited
- 11.2.1 CSL Limited Corporation Information
- 11.2.2 CSL Limited Overview
- 11.2.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.2.4 CSL Limited Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 CSL Limited Recent Developments
- 11.3 Croda
- 11.3.1 Croda Corporation Information
- 11.3.2 Croda Overview
- 11.3.3 Croda Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.3.4 Croda Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Croda Recent Developments
- 11.4 SEPPIC
- 11.4.1 SEPPIC Corporation Information
- 11.4.2 SEPPIC Overview
- 11.4.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.4.4 SEPPIC Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 SEPPIC Recent Developments
- 11.5 Novavax
- 11.5.1 Novavax Corporation Information
- 11.5.2 Novavax Overview
- 11.5.3 Novavax Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.5.4 Novavax Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Novavax Recent Developments
- 11.6 SPI Pharma
- 11.6.1 SPI Pharma Corporation Information
- 11.6.2 SPI Pharma Overview
- 11.6.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.6.4 SPI Pharma Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 SPI Pharma Recent Developments
- 11.7 Phibro
- 11.7.1 Phibro Corporation Information
- 11.7.2 Phibro Overview
- 11.7.3 Phibro Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.7.4 Phibro Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 Phibro Recent Developments
- 11.8 SDA BIO
- 11.8.1 SDA BIO Corporation Information
- 11.8.2 SDA BIO Overview
- 11.8.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.8.4 SDA BIO Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 SDA BIO Recent Developments
- 11.9 Invivogen
- 11.9.1 Invivogen Corporation Information
- 11.9.2 Invivogen Overview
- 11.9.3 Invivogen Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.9.4 Invivogen Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 Invivogen Recent Developments
- 11.10 Tj Kaiwei
- 11.10.1 Tj Kaiwei Corporation Information
- 11.10.2 Tj Kaiwei Overview
- 11.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.10.4 Tj Kaiwei Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.10.5 Tj Kaiwei Recent Developments
- 11.11 OZ Biosciences
- 11.11.1 OZ Biosciences Corporation Information
- 11.11.2 OZ Biosciences Overview
- 11.11.3 OZ Biosciences Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.11.4 OZ Biosciences Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.11.5 OZ Biosciences Recent Developments
- 11.12 Brenntag Biosector
- 11.12.1 Brenntag Biosector Corporation Information
- 11.12.2 Brenntag Biosector Overview
- 11.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.12.4 Brenntag Biosector Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.12.5 Brenntag Biosector Recent Developments
- 11.13 MVP Laboratories
- 11.13.1 MVP Laboratories Corporation Information
- 11.13.2 MVP Laboratories Overview
- 11.13.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.13.4 MVP Laboratories Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.13.5 MVP Laboratories Recent Developments
- 11.14 Zhuoyue
- 11.14.1 Zhuoyue Corporation Information
- 11.14.2 Zhuoyue Overview
- 11.14.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.14.4 Zhuoyue Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.14.5 Zhuoyue Recent Developments
- 11.15 Aphios
- 11.15.1 Aphios Corporation Information
- 11.15.2 Aphios Overview
- 11.15.3 Aphios Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.15.4 Aphios Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.15.5 Aphios Recent Developments
12 Industry Chain and Sales Channels Analysis
- 12.1 Vaccine Adjuvants Industry Chain Analysis
- 12.2 Vaccine Adjuvants Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
- 12.3 Vaccine Adjuvants Production Mode & Process
- 12.4 Vaccine Adjuvants Sales and Marketing
- 12.4.1 Vaccine Adjuvants Sales Channels
- 12.4.2 Vaccine Adjuvants Distributors
- 12.5 Vaccine Adjuvants Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
- 13.1 Vaccine Adjuvants Industry Trends
- 13.2 Vaccine Adjuvants Market Drivers
- 13.3 Vaccine Adjuvants Market Challenges
- 13.4 Vaccine Adjuvants Market Restraints
14 Key Findings in The Global Vaccine Adjuvants Study
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Author Details
- 15.3 Disclaimer